Cellular membranes play host to a wide variety of morphologically and chemically complex 20 processes. Although model membranes, like liposomes, are already widely used to reconstitute 21 and study these processes, better tools are needed for making model bilayers that faithfully mimic 22 cellular membranes. Existing methods for fabricating cell-sized (µm) or organelle-sized (tens to 23 hundreds of nm) lipid vesicles have distinctly different requirements. Of particular note for biology, 24 it remains challenging for any technique to efficiently encapsulate fragile cargo molecules or to 25 generate liposomes with stable, asymmetric lipid-leaflets within the bilayer. Here we describe a 26 tunable microfluidic device and protocol for fabricating liposomes with desired diameters ranging 27 from ~10 µm to ~100 nm. Lipid vesicle size is templated by the simple inclusion of a polycarbonate 28 filter within the microfluidic system and tuned with flow rate. We show that the vesicles made with 29 our device are stable, unilamellar, lipid asymmetric, and capable of supporting transmembrane 30 protein assembly, peripheral membrane protein binding, as well as soluble cargo encapsulation 31 (including designer nanocages for biotechnology applications). These fabricated vesicles provide 32 a new platform for studying the biophysically rich processes found within lipid-lipid and lipid-33 protein systems typically associated with cellular membranes. 34
would enable researchers to reconstitute complex cellular phenomena in vitro for detailed 48
characterizations. 49
Microfluidic techniques are effective for: 1) synthesizing liposomes of defined diameter 50 ranges; 2) encapsulating a variety of solute molecules; 3) lowering reagent consumption, and 4) 51 generating lipid bilayers that comprise mixtures of different lipid species. Final liposome size 52 depends on the starting microfluidic droplet size, and this necessitates fabricating channels that 53 are roughly the same size as the desired vesicles. However, fabrication of micro (> 1 µm) or 54 nanoscale (< 1 µm) channels typically requires access to cleanroom facilities and fabrication 55 expertise. Micro channels are also prone to clogging and require filtered samples and, in many 56 cases, chemical functionalization of the channel to promote stable droplet formation. Fabrication 57 and operation of smaller channels (< 1 µm) requires even finer control over device processing 58 and fluidic control parameters. As a result, few techniques exist for the formation of LUVs and no 59 technique currently exists that can be tuned to generate either GUVs or LUVs using the same 60 methodology. 61
Here we report a microfluidic device and protocol for the fabrication of either cell-sized 62
GUVs or organelle-sized LUVs. This microfluidic approach combines a y-mixer design with cross-63 flow filter emulsification to rapidly produce micro or nanoscale lipid-stabilized droplets that are 64 subsequently converted to liposomes by the phase-transfer method [9] . Torque-balance modeling 65 of droplet formation suggested that final liposome size depends on the polycarbonate filter pore 66 size, allowing us to create ~ 8 µm liposomes (GUVs) using a 5 µm polycarbonate filter and ~ 300 67 nm liposomes (LUVs) using a 100 nm polycarbonate filter. Our experiments confirm that liposome 68 size can be controlled by substituting polycarbonate filters with different pore sizes. By utilizing a 69 number of chemical, biological and microscopy assays we show that at both scales the majority 70 of generated liposomes are unilamellar and that only a small subset possess any solvent 71 contamination as detected by electron cryo-microscopy. Furthermore, we verify the ability of LUVs 72 created with a complex phospholipid composition to bind to, and be remodeled by, the ESCRT-73 
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Templating vesicle size. We tested whether embedding polycarbonate filters with 93 defined pore sizes within a microfluidic device could be used to create liposomes at either the 94 micro or nanoscale using the Phase-Transfer (PT) method [9, 10] . In this approach, a dispersed 95 phase (solution to be encapsulated) is driven through a rigid filter into a shearing continuous 96 phase (immiscible with the dispersed phase) under cross-flow emulsification conditions leading 97 to the formation of droplets ( Figure 1a ). Droplet size primarily depends on the membrane pore 98 size and can be tuned by adjusting the wall shear stress (which is a function of cross-flow velocity 99 and fluid properties) [11] . However, beyond a certain cross-flow velocity droplet size reaches a 100 plateau [12, 13] . Our microfluidic device takes advantage of this saturation regime to produce 101 droplets of consistent size while also significantly reducing reagent consumption (requiring only 102 hundreds of µL as compared to tens of mL for traditional systems [14] ). The device consists of two 103 input channels and an off-the-shelf polycarbonate filter. Each device can be re-used multiple 104 times, takes 35 minutes to fabricate and costs less than $2 ( Figure 1b ). The geometry of the oil 105 input channel (width; 250 µm, height; 31 µm) results in laminar flow with high shear stress 106 throughout. Each polycarbonate layer, along with the polycarbonate filter, is added sequentially 107 (Supplementary Figure 1 ) and permanently bonded through thermal fusion for a maximum bond 108 strength of 4.5 MPa ( Supplementary Figure 2) .
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The existence of a droplet-size invariant regime was first established theoretically by 110 applying a torque-balance model at the surface of the filter pore [11] . Depending on the mode of 111 deformation, we identified droplet-size invariant regions for 5 µm and 100 nm pore polycarbonate 112 filters ( Supplementary Figure 3a and 3b ). Theoretical modeling, based on the geometric 113 constraints ( Supplementary Table 1 ) used in this work, predicted small droplet diameter variation 114 with a continuous phase flow rate set to 80 µL/min or greater. The existence of this region was 115 confirmed experimentally after the transformation of droplets into liposomes using the PT method 116 ( Figure 1c ), which has been shown to preserve initial droplet size upon centrifugation [9, 15] . 117
Dynamic light scattering confirmed droplet-size invariance for a 100 nm filter pore across a variety 118 of flow rates (80 µL/min to 230 µL/min) ( Supplementary Figure 3c) . 119
Integration of a 5 µm polycarbonate filter into the microfluidic device lead to the formation 120 of cell-sized lipid vesicles (GUVs) (8±5 µm) (mean±s.d., n=176) ( Figure 1d here is, on average, smaller and more uniform than GUVs prepared by other microfluidic [16, 17] or 125 other methods [17, 18] and does not require detergent stabilization [15] . Our technique also enables 126 rapid encapsulation of material within the lumen. In addition, by substituting a 5 µm filter for a 100 127 nm filter we are able to generate organelle-sized lipid vesicles (LUVs) of 300±80 nm (mean±s.d., 128 n=9, Figure 1f ). CryoEM enabled direct visualization of LUVs and confirmed the formation of 129 vesicles with intact, unilamellar lipid bilayers ( Figure 1g ). Compared to spontaneous 130 vesiculation [19] or droplet-extrusion [19] , the technique developed here confers improved control 131 over lipid leaflet placement, lamellarity [20] , size and distribution. Lamellarity, permeability, and solvent contamination. We investigated GUV 147 lamellarity through encapsulation of the dye, carboxyfluorescein. Alpha-hemolysin (aH), a 148 membrane-binding and pore-forming toxin was added to the outside of liposomes. In a series of 149 steps, monomers of aH adsorb on the lipid bilayer, followed by assembly into a heptameric pore 150 that spans the lipid bilayer [21] . We observed that aH nanopores successfully assembled within the 151 lipid bilayer and lead to the diffusion of fluorescent molecules out of the vesicle lumen (Figure 2a ). 152
Functional alpha-hemolysin insertion demonstrates three things, 1) the lipid bilayer is capable of 153 supporting membrane insertion and pore formation 2) the lipid bilayer is unilamellar and 3) the 154 bilayer remains stable following aH pore formation (Figure 2b) . 155
Next, we probed the lamellarity of nanoscale vesicles utilizing two distinctly different 156 assays: fluorescence quenching and cryoEM. First, we utilized sodium hydrosulfite to quench 157 fluorescence from trace NBD-PC lipids. In the vicinity of the fluorophore (NBD) sodium 158 hydrosulfite quenches the fluorescence by reducing the dye. A perfectly symmetric lipid bilayer 159 will result in the reduction of 50% of the signal if the fluorophore (NBD-PC) is evenly distributed 160 between the two leaflets upon exposure to the quenching agent [9] . We generated symmetric 161 vesicles composed of POPC/POPS/Cholesterol/NBD-PC (44.8:36.9:17.7:0.5 mol%) and 162 measured NBD-PC fluorescence. For liposomes fabricated with NBD-PC in both the inner and 163 outer leaflets, addition of the quencher reduced total fluorescence by 47% (Figure 2c ), suggesting 164 that the dye was evenly distributed in both leaflets and confirming that the majority of liposomes of sugars are detrimental for cryoEM analysis because they lead to significant reductions in 174 contrast [22] . 175
Next, we generated LUVs with asymmetric lipid leaflets, with an inner leaflet that Figure 6) we cannot rule out the presence of trace 215 amounts of oil within the lipid bilayer. Interestingly, the observed mineral oil collection in lenses is 216 reminiscent of the fatty acid lenses that form in the endoplasmic reticulum during lipid droplet 217 biogenesis [26] . Our methodology can potentially be used to reconstitute and study this 218
phenomenon. 219
Next we utilized nanotube pulling experiments to probe the dynamic response and stability 220 of the lipid membrane. A single lipid tubule pulled from the surface of a GUV requires a constant 221 supply of liquid lipid in order to maintain structural integrity [27] . As expected, biotin-coated silica 222 beads conjugated with Traptavidin positioned with an optical trap (Supplemental Figure 7) can be 223 13 used to pull ~ 50 nm diameter lipid tubules from GUVs incorporating POPC/POPS/Cholesterol 224 with Biotin-PE ( Figure 3d ) and trace amounts of Rhodamine-PE (Figure 3e ). These nanotubes 225 are stable and can extend to tens of micrometers in length. 226
We also assayed whether vesicles generated using our device are suitable substrates for 227 peripheral membrane-binding proteins. CHMP1B is a human ESCRT-III protein implicated in 228 membrane deformation processes such as recycling tubule biogenesis from endosomes [6, 28, 29] . 229 CHMP1B accumulation on the surface of a lipid membrane requires the presence of negatively-230 charged lipid headgroups, like POPS. In agreement with previous observations [6] , initially 231 spherical liposomes (Figure 3f 
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Encapsulation of synthetic and organic macromolecules. Liposomes have been used 253 extensively as cargo carriers because the inner lumen of the liposome is protected from the 254 exterior environment by the lipid bilayer. By including different cargoes in the first stage of 255 emulsion generation, we encapsulated two cargoes with different properties. An advantage of our 256 method is the ability to create GUVs and LUVs incorporating diverse solution conditions, e.g. high 257
ionic strength buffers (> 350 mM NaCl), for encapsulation of target proteins that would otherwise 258 polymerize or assemble under physiological conditions. 259
For encapsulation we first loaded LUVs with computationally designed, self-assembling 260 25 nm dodecahedral nanocages (Figure 4a) [30] . These recently reported [30] nanocages hold great 261 promise for drug delivery and synthetic biology applications, including as cargo carriers [31] , as 262 imaging probes [32] and as scaffolds for vaccine design [33] . Initially, we purified and visualized 25nm 263 diameter aldolase nanocages [30, 34] by negative stain TEM ( Supplementary Figure 8) . We then 264 demonstrated nanocage encapsulation within vesicles manufactured in our microfluidic device by 265 3 methods: 1) We observe that aldolase activity is sequestered within liposomes, but can be 266 subsequently released upon the addition of a detergent (Figure 4b) ; 2) TEM imaging revealed 267 controlled nanocage release from detergent-exposed liposomes ( Supplementary Figure 9 and 268 Supplementary Figure 10a) ; 3) Finally, direct visualization by cryoEM demonstrated that the 269 protein nanocages inside the synthesized liposomes matched the expected 25 nm size and 270 assembled architecture of the designed structure (Figure 4c,d and Supplementary Figure 10b ) [30] . 271
In addition to these dodecahedral nanocage assemblies, we also encapsulated GFP (Green 272 Fluorescent Protein) within both GUVs and LUVs, as determined by fluorescence microscopy 273 (Figure 4e-f ). Developing efficient means by which biological macromolecules can be 274 encapsulated and protected while maintaining their structure and function will prove vital for future 275 applications. 276
Conclusion 277
We have developed a simple, inexpensive and modular microfluidic approach for the formation of 
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Nanoemulsion and LUV formation. Lipid handling and preparation procedures followed those of 300 previously published protocols [35, 36] . Phospholipids (POPC/POPS/Cholesterol (45.3:36.9:17.7 mol%))
301
(unless otherwise stated, this lipid ratio was used for all formulations and is the standard lipid mixture) 
312
GUV formation and carboxyfluorescein encapsulation. Following the same protocol as outlined for 313 LUVs, microemulsions were synthesized by keeping the dispersed phase constant at 5 µL/min and the oil 314 flow rate constant at 120 µL/min. Following incubation at room temperature, emulsions were added to the 315 capture vial and centrifuged (10 minutes at 9,000 x g). Carboxyfluorescein (350 mM NaCl, 50 mM Tris-HCl 316 pH 7.0, 5% (w/v) Glycerol and 5 mM β-mercaptoethanol) was encapsulated within GUVs at a final 317 concentration of 50 µm.
318
Liposome leaflet asymmetry assay. The inner lipid leaflet was composed of POPC/NBD-PC (99.5:0.5 319 mol.%). The outer leaflet was composed exclusively of POPS (100 mol.%). Emulsion preparation and 320 collection followed previously described steps except for the addition of NBD-PC to the emulsion formation 321 phase. Unlabeled POPS oil-lipid mixture was diluted with mineral oil (1:1). 170 µl of this mixture was placed 322 18 on top of 130 µl of 1xPBS buffer in a 2 ml microtube and allowed to equilibrate for 20 minutes at room 323 temperature. Emulsions were centrifuged at 300 g for 10 minutes at room temperature. Following previously 324 published protocols [37] , 10 µl of unconcentrated liposome solution and 10 µl of buffer were added to one 325 well and 20 µl of buffer was added to another. After setting the baseline, 0.5 µl of 1 M sodium hydrosulfite 326 prepared in 1xPBS was added to the sample followed by the addition of 2 µl of 10% Triton X-100.
327
Aldolase enzyme activity assay. The 2-keto-3-deoxy-6-phosphogluconate (KDPG) aldolase activity of 328 the I3-01 nanocage domain was monitored using an L-lactic acid dehydrogenase (LDH)-coupled 329 assay [34, 38] . 10 μL of nanocage-encapsulated liposomes were mixed with 90 μL of 1xPBS, 0.1 mM NADH, 
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/pixel/sec at the specimen. SerialEM [39] was used to facilitate low-dose imaging and semi-automated data 344 collection, and each movie was recorded as a stack of 40 subframes, each of which was accumulated for 345 0.2 s, totaling ~39 e-/Å 2 at the specimen. Frames were aligned and summed by using MotionCor2 [40] .
